Algert Global’s Tango Therapeutics TNGX Stock Holding History

Algert Global’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.05M	Buy	+145,640	New	+$2.03M	0.05%	596
2025 Q2	–	Sell	-65,560	Closed	-$90K	–	1347
2025 Q1	$90K	Sell	65,560 -96,740	-60%	-$238K	﹤0.01%	1134
2024 Q4	$502K	Buy	+162,300	New	+$754K	0.01%	908
2023 Q3	–	Sell	-40,088	Closed	-$133K	–	1255
2023 Q2	$133K	Hold	40,088	–	–	0.01%	1021
2023 Q1	$158K	Sell	40,088 -2,385	-6%	-$13.8K	0.01%	1046
2022 Q4	$308K	Buy	42,473 +8,050	+23%	+$56.6K	0.02%	927
2022 Q3	$125K	Buy	34,423 +17,453	+103%	+$74.5K	0.01%	1088
2022 Q2	$77K	Buy	+16,970	New	+$103K	0.01%	1134

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return